Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
ID: 336070Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/336070

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-21-321.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for Cancer Center Support Grants (CCSGs) aimed at NCI-designated Cancer Centers under the P30 funding mechanism. These grants are designed to support three types of cancer centers: Comprehensive, Clinical, and Basic Cancer Centers, with the objective of fostering collaborative cancer research and enhancing integrated scientific agendas across institutions. The CCSGs are crucial for advancing cancer discovery, prevention, and treatment, while also contributing to community health through research dissemination and outreach efforts. Interested applicants can apply for funding up to $1.5 million, with the application deadline set for January 7, 2026. For further inquiries, applicants may contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or refer to the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-321.html.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-21-321-Full-Announcement.html
    PAR-21-321.html
    The Department of Health and Human Services, through the National Institutes of Health, is inviting applications for Cancer Center Support Grants (CCSGs) aimed at NCI-designated Cancer Centers. These grants, categorized under the P30 code, will support three types of centers: Comprehensive, Clinical, and Basic Cancer Centers. The purpose is to foster collaborative cancer research, enhance integrated scientific agendas, and facilitate the development of shared resources. Cancer Centers backed by these grants are expected to be instrumental in cancer discovery, prevention, and treatment, contributing significantly to community health through research dissemination and outreach efforts. The application process follows strict compliance with guidelines structured around the Multi-Project instructions. The program encourages partnerships and transdisciplinary collaborations and stipulates eligibility criteria for various organizations, emphasizing a commitment to diversity among staff and leadership. The expiration date of the funding opportunity is set for January 8, 2026. This funding opportunity aims to solidify a comprehensive cancer research infrastructure across the nation, ensuring improved outcomes for cancer prevention and treatment efforts.
    Similar Opportunities
    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for Cancer Center Support Grants (CCSGs) aimed at supporting NCI-designated Cancer Centers under the P30 activity code. These grants are designed to foster excellence in cancer research by integrating diverse research activities and enhancing collaboration among institutions, with eligible applicants including various educational and community organizations. The CCSGs emphasize a transdisciplinary approach to cancer research, with funding amounts of up to $1.2 million for Basic Cancer Centers and $1.4 million for Clinical Cancer Centers per year, potentially extending over five years based on merit. Interested parties can find more information and application details at the NIH website, and inquiries can be directed to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV. The application deadline is set for October 12, 2121.
    Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research," aimed at enhancing cancer research through innovative technologies. This initiative encourages currently funded NCI P30 Cancer Center Support Grants (CCSG) recipients to expand their research by integrating new technical approaches developed through the NCI's Innovative Molecular Analysis Technologies (IMAT) program. The program is designed to foster interdisciplinary collaboration and promote independent validation of emerging technologies, thereby accelerating scientific discovery in cancer research. Interested applicants can apply for up to $150,000 per year, with a total funding pool of approximately $600,000 available for up to three awards. Applications are due by 5 PM local time on October 2, 2024, and further inquiries can be directed to grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-015.html.
    National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health, through the National Cancer Institute (NCI), invites applications for Program Project grants (P01) aimed at fostering collaborative, multidisciplinary cancer research for the years 2023, 2024, and 2025. Applicants must propose at least three interrelated research projects and an Administrative Core, all centered around a common theme within the expansive field of cancer research, which includes areas such as cancer biology, prevention, diagnosis, treatment, and control. This funding opportunity is crucial for advancing cancer research and enhancing the effectiveness of collaborative efforts, with applications due by May 7, 2026. Interested parties can find more information and application guidelines at the provided link, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the Central Coordinating Site (CCS) for the Polycystic Kidney Disease (PKD) Research Core Centers through Funding Opportunity Number RFA-DK-25-015. The CCS will collaborate with four PKD Research Core Centers to enhance understanding of PKD and promote resource sharing, providing essential administrative support, managing data sharing, and administering pilot project funding. This initiative is crucial for fostering a diverse and collaborative research environment to address the challenges of PKD effectively. The funding opportunity anticipates approximately $1.1 million for one award in FY 2025, with annual budgets around $350,000. Interested applicants must submit their proposals via Grants.gov by November 14, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Cancer Prevention and Control Clinical Trials Planning Grant Program (U34), aimed at facilitating well-planned clinical trials that enhance cancer prevention, treatment, and survivorship care. This funding opportunity seeks to address critical gaps in trial planning by acquiring essential data for finalizing protocols, including feasibility assessments and stakeholder engagement strategies. The program is particularly significant for improving cancer-related health behaviors and outcomes, with grants available up to $600,000 for trials including pilot studies, over a maximum of three years. Interested applicants, including higher education institutions and nonprofit organizations, must submit their proposals by September 7, 2025, and can direct inquiries to OERWebmaster03@od.nih.gov for further information.
    Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE)" aimed at fostering collaborations between institutions serving underserved populations and NCI-designated Cancer Centers. The initiative seeks to enhance cancer research capacity, promote workforce diversity, and implement community outreach initiatives to address cancer health disparities. This program is vital for developing comprehensive research projects that include administrative cores, research education, and outreach efforts, ultimately contributing to a stronger national cancer program. Eligible applicants can request funding of up to $2.2 million over five years, with the application submission period starting on December 15, 2023. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    The Chronic Pancreatitis Clinical Research Consortium (CPCRC)- Clinical Centers (CPCRC-CCs) (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Chronic Pancreatitis Clinical Research Consortium (CPCRC), inviting U01 applications for Clinical Centers to conduct research on chronic pancreatitis, diabetes, and pancreatic cancer. The initiative aims to continue the consortium's work by collecting clinical data and biospecimens to identify biomarkers for risk stratification and disease progression, ultimately enhancing understanding and treatment of these conditions. With an estimated funding of $6.5 million for the 2025 fiscal year, applications are due by October 18, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Cancer Prevention Clinical Trials Network (CP-CTNet) to establish sites for early-phase cancer prevention clinical trials. The initiative aims to develop and conduct trials that assess the safety and efficacy of various preventive agents and interventions targeting specific biological processes associated with cancer development, with a focus on recruiting high-risk participants and conducting multi-institutional studies. This funding underscores the importance of advanced research in cancer prevention, with a total funding amount of $8.75 million annually to support five awards over six years, each with a budget not exceeding $1.375 million. Interested applicants must submit a letter of intent by August 23, 2024, and a complete application by September 30, 2024; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Small Grants Program for Cancer Research for Years 2023, 2024, and 2025 (NCI Omnibus) (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the NCI Small Grants Program for Cancer Research (R03) for the years 2023 to 2025. This funding opportunity is designed to support small-scale research projects on cancer that can be completed within a two-year timeframe and with limited resources, including pilot studies, secondary data analyses, and the development of research methodologies or technologies. Grants of up to $50,000 per year are available to a wide range of eligible applicants, including higher education institutions, nonprofits, and various community organizations. Interested parties should submit their applications electronically via Grants.gov, with the first submission deadline having been January 22, 2023, and subsequent deadlines continuing through 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Cancer Prevention and Control Clinical Trials Planning Grant Program (R34), aimed at enhancing clinical trials focused on cancer prevention and control. This program seeks to address critical gaps in knowledge regarding study populations, interventions, and operational challenges, facilitating the collection of essential data to finalize protocols for future clinical trials. The initiative is particularly important for improving cancer-related health behaviors, screening, and the long-term outcomes of cancer survivors. Eligible applicants include a diverse range of organizations, with funding available up to $600,000 over three years, and applications are due by September 7, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.